Choking caused by antipsychotics;Verslikking en verstikking door antipsychotica

Tijdschrift voor Psychiatrie

Volumn 49, Issue 10, 2007, Pages 743-751

  Timmer, T J ^a   Fouwels, A J ^a,b  

^a AMC de Meren ^*  (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antipsychotic agents; Asphyxia; Deglutition disorders; Dyskinesias; Dystonia

Indexed keywords

CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DECANOIC ACID; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; PAROXETINE; PHENOTHIAZINE DERIVATIVE; RISPERIDONE; TRIFLUOPERAZINE;

ARTICLE; ASPHYXIA; BREATHING; BREATHING DISORDER; BREATHING MUSCLE; CLINICAL EXAMINATION; DYSPHAGIA; FLUOROSCOPY; HUMAN; MEDLINE; MUSCLE SPASM; REFLEX; RISK FACTOR; VOMITING REFLEX;

AIRWAY OBSTRUCTION; ANTIPSYCHOTIC AGENTS; ASPHYXIA; DEGLUTITION DISORDERS; DYSKINESIA, DRUG-INDUCED; HUMANS; PREVALENCE; RISK FACTORS;

EID: 35348983560     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Ahmed, S., Chengappa, K.N., Naidu, V.R., e.a. (1998). Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. The Journal of Clinical Psychiatry, 59, 472-477.
2. American Psychiatric Association. (1992). Tardive dyskinesia: a task force report of the American Psychiatric Association. Washington, DC: American Psychiatric Association.
3. Baldessarini, R.J., & Frankenburg, F.R. (1991). Clozapine. A novel antipsychotic agent. The New England Journal of Medicine, 324, 746-754.
4. Barach, E., Dubin, L.M., Tomlanovich, M.C., e.a. (1989). Dystonia presenting as upper airway obstruction. The Journal of Emergency Medicine, 7, 237-240.
5. Bashford, G., & Bradd, P. (1996). Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. Journal of Geriatric Psychiatry and Neurology, 9, 133-135.
6. Bazemore, P.H., Tonkonogy, J., & Ananth, R. (1991). Dysphagia in psychiatric patients: clinical and videofluoroscopic study. Dysphagia, 6, 2-5.
7. Brody, A.L. (1996). Acute dystonia induced by rapid increase in risperidone dosage. Journal of Clinical Psychopharmacology, 16, 461-462.
8. Brown, R.P., & Kocsis, J.H. (1984). Sudden death and antipsychotic drugs. Hospital & Community Psychiatry, 35, 486-491.
9. Bulling, M. (1999). Drug-induced dysphagia. Australian and New Zealand Journal of Medicine, 29, 748.
10. Burke, R.E., Fahn, S., Marsden, C.D., e.a. (1985). Validity and reliability of a rating scale for the primary torsion dystonias. Neurology, 35, 73-77.
11. Chouinard, G., Ross-Chouinard, A., Gauther, S., e.a. (1984). An extrapyramidal rating scale for idiopathic and neuroleptic induced parkinsonism and dyskinesia. Gepresenteerd op het 14de congres van het Collegium Internationale Neuro-Psychopharmacologicum, Florence, Italië.
12. Coura, S.H., Alho Filho, J.L., Leite, J.G., e.a. (1980). Cerebral lateralization and unilateral ect. The British Journal of Psychiatry: the Journal of Mental Science, 136, 608.
13. Craig, T.J., & Lin, S.P. (1981). Mortality among psychiatric inpatients. Age-adjusted comparison of populations before and after psychotropic drug era. Archives of General Psychiatry, 38, 935-938.
14. Craig, T.J., Richardson, M.A., Bark, N.M., e.a. (1982). Impairment of swallowing, tardive dyskinesia, and anticholinergic drug use. Psychopharmacology Bulletin, 18, 84-86.
15. Dave, M. (1994). Clozapine-related tardive dyskinesia. Biological Psychiatry, 35, 886-887.
16. Davies, A.E., Kidd, D., Stone, S.P., e.a. (1995). Pharyngeal sensation and gag reflex in healthy subjects. Lancet, 345, 487-488.
17. Davis, J.M., & Zhang, M. (1988). Sudden death in psychiatric patients. Psychiatric Annals, 18, 311-319.
18. Ehrt, U., Fritze, F., & Aarsland, D. (2005). Respiratory dyskinesia as discontinuation effect of risperidone. Journal of Clinical Psychopharmacology, 25, 609.
19. Flaherty, J.A., & Lahmeyer, H.W. (1978). Laryngeal-pharyngeal dystonia as a possible cause of asphyxia with haloperidol treatment. The American Journal of Psychiatry, 135, 1414-1415.
20. Gerlach, J., & Peacock, L. (1994). Motor and mental side effects of clozapine. The Journal of Clinical Psychiatry, 55(Suppl. B), 107-109.
21. Gregory, R.P., Smith, P.T., & Rudge, P. (1992). Tardive dyskinesia presenting as severe dysphagia. Journal of Neurology, Neurosurgery and Psychiatry, 55, 1203-1204.
22. Guy, W.A. (1976). Abnormal Involuntary Movement Scale (AIMS). In ECDEU Assessment Manual for Psychopharmacology (pp. 534-537). Washington, DC: U.S. Department of Health Education and Welfare.
23. Harten, P.N. van. (2000). Bewegingsstoornissen door antipsychotica: diagnostiek en behandeling. Amsterdam: Boom.
24. Hayashi, T., Nishikawa, T, Koga, I., e.a. (1996). Prevalence of and risk factors for respiratory dyskinesia. Clinical Neuropharmacology, 19, 390-398.
25. Hong, K.S., Cheong, S.S., Woo, J.M., e.a. (1999). Risperidone-induced tardive dyskinesia. The American Journal of Psychiatry, 156, 1290.
26. Hughes, T.A., Shone, G., Lindsay, G., e.a. (1994). Severe dysphagia associated with major tranquillizer rreatment. Postgraduate Medical Journal, 70, 581-583.
27. Hussar, A.E., & Bragg, D.G. (1969). The effect of chlorpromazine on the swallowing function in chronic schizophrenic patients. The American Journal of Psychiatry, 126, 570-573.
28. Kane, J.M., Woerner, M.G., Pollack, S., e.a. (1993). Does clozapine cause tardive dyskinesia? The Journal of Clinical Psychiatry, 54, 327-330.
29. Koek, R.J., & Pi, E.H. (1989). Acute laryngeal dystonic reactions to neuroleptics. Psychosomatics, 30, 359-364.
30. Komatsu, S., Kirino, E., Inoue, Y., e.a. (2005). Risperidone withdrawal-related respiratory dyskinesia: a case diagnosed by spirography and fibroscopy. Clinical Neuropharmacology, 28, 90-93.
31. Leopold, N.A. (1996). Dysphagia in drug-induced parkinsonism: a case report. Dysphagia, 11, 151-153.
32. Loonen, A.J., Doorschot, C.H., van Hemert, D.A., e.a. (2001). The schedule for the assessment of drug-induced movement disorders (SADIMOD): inter-rater reliability and construct validity. The International Journal of Neuropsychopharmacology, 4, 347-360.
33. Lykouras, L., Yannakis, R., Hatzimanolis, J., e.a. (1999). Two cases of risperidone-induced tardive dyskinesia and a review of the literature. European Psychiatry: the Journal of the Association of European Psychiatrists, 14, 245-247.
34. Margolese, H.C., Chouinard, G., Kolivakis, T.T., e.a. (2005). Tardive dyskinesia in the era of typical and atypical antipsychotics. Parr 2: Incidence and management strategies in patients with schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 50, 703-714.
35. Massengill, R., Jr., & Nashold, B. (1969). A swallowing disorder denoted in tardive dyskinesia patients. Acta oto-laryngologica, 68, 457-458.
36. McCarthy, R.H., & Terkelsen, K.G. (1994). Esophageal dysfunction in two patients after clozapine treatment. Journal of Clinical Psychopharmacology, 14, 281-283.
37. McDanal, C.E., Jr. (1981). Haloperidol and laryngeal-pharyngeal dystonia. The American Journal of Psychiatry, 138, 1262-1263.
38. Mehtonen, O.P., Aranko, K., Mälkonen, L., e.a. (1991). A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatrica Scandinavica, 84, 58-64.
39. Modestin, J., Krapf, R., & Böker, W. (1981). A fatality during haloperidol treatment: mechanism of sudden death. The American Journal of Psychiatry, 138, 1616-1617.
40. Molho, E.S., & Factor, S.A. (1999). Possible tardive dystonia resulting from clozapine therapy. Movement Disorders, 14, 873-874.
41. Nair, S., Saeed, O., Shahab, H., e.a. (2001). Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect? General Hospital Psychiatry, 23, 231-232.
42. Nishikawa, T., Kaneda, W., Uegaki, A., e.a. (1992). Respiratory dyskinesia: a variety of clinical forms differentially diagnosed by usinga spirograph. Clinical Neuropharmacology, 15, 315-321.
43. Pearlman, C. (1994). Clozapine, nocturnal sialorrhea, and choking. Journal of Clinical Psychopharmacology, 14, 283.
44. Simpson, G.M., & Angus, J.W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica, 212(Suppl.), 11-19.
45. Sliwa, J.A., & Lis, S. (1993). Drug-induced dysphagia. Archives of Physical Medicine and Rehabilitation, 74, 445-447.
46. Sokoloff, L.G., & Pavlakovic, R. (1997). Neuroleptic-induced dysphagia. Dysphagia, 12, 177-179.
47. Spivak, B., Mester, R., Abesgaus, J., e.a. (1997). Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. The Journal of Clinical Psychiatry, 58, 318-322.
48. Splaingard, M.L., Hutchins, B., Sulton, L.D., e.a. (1988). Aspiration in rehabilitation patients: videofluoroscopy vs bedside clinical assessment. Archives of Physical Medicine and Rehabilitation, 69, 637-640.
49. Stewart, J.T. (2001). Reversible dysphagia associated with neuroleptic treatment. Journal of the American Geriatrics Society, 49, 1260-1261.
50. Stewart, J.T. (2003). Dysphagia associated with risperidone therapy. Dysphagia, 18, 274-275.
51. Weiden, P., & Harrigan, M. (1986). A clinical guide for diagnosing and managing patients with drug-induced dysphagia. Hospital & Community Psychiatry, 37, 396-398.
52. Yassa, R., & Jones, B.D. (1985). Complications of tardive dyskinesia: a review. Psychosomatics, 26, 305-307, 310, 312-313.
53. Yassa, R., & Lal, S. (1986). Respiratory irregularity and tardive dyskinesia. A prevalence study. Acta Psychiatrica Scandinavica, 73, 506-510.